轻度高碳酸血症对院外心脏骤停后ST段抬高型心肌梗死患者心肌损伤的影响:TAME试验探索性事后分析
该研究为TAME试验的事后探索性分析,纳入810例急性心肌梗死患者,其中593例为STEMI。比较靶向轻度高碳酸血症与正常碳酸血症对心肌损伤(峰值hs-cTnT或cTnI)的影响。结果显示两组肌钙蛋白水平无差异(cTnI几何均值比1.18,95%CI 0.79-1.77;hs-cTnT 1.20,95%CI 0.88-1.63),乳酸清除率、院内死亡率(39% vs 40.5%,RR 0.97,95%CI 0.82-1.14)及6个月神经功能良好结局(44.3% vs 48.5%,RR 1.09,95%CI 0.92-1.29)均无显著差异。成功PCI的STEMI患者中各结局同样无显著差异。
要点
- 在TAME试验的593例STEMI患者中,轻度高碳酸血症组与正常碳酸血症组肌钙蛋白水平无差异(cTnI几何均值比1.18,95%CI 0.79-1.77;hs-cTnT 1.20,95%CI 0.88-1.63)。
- STEMI患者院内死亡率:轻度高碳酸血症组39%(112/287)vs 正常碳酸血症组40.5%(124/306),RR 0.97(95%CI 0.82-1.14)。
- 6个月神经功能良好结局:轻度高碳酸血症组44.3%(129/267)vs 正常碳酸血症组48.5%(125/282),RR 1.09(95%CI 0.92-1.29)。
- 成功PCI的STEMI患者中,按治疗分配各结局均无显著差异。
- 作者结论:在TAME试验的STEMI患者中,靶向轻度高碳酸血症未改变心肌损伤、院内死亡率或6个月神经功能结局。
适用人群与场景
- TAME试验中诊断为急性心肌梗死的810例患者(占TAME试验1700例的49%),其中593例为STEMI(73%)。
- TAME试验纳入的是院外心脏骤停后昏迷的成人患者。
- 本分析为事后探索性研究,比较靶向轻度高碳酸血症与正常碳酸血症。
研究设计与关键结果
- 研究类型:TAME试验的事后探索性分析;样本量:810例急性心肌梗死患者,其中593例STEMI;轻度高碳酸血症组287例(48%),正常碳酸血症组306例(52%)。
- 主要终点:住院期间峰值hs-cTnT或cTnI评估的心肌损伤;562例STEMI患者(95%)有肌钙蛋白数据。
- 肌钙蛋白几何均值比(轻度高碳酸血症/正常碳酸血症):cTnI 1.18(95%CI 0.79-1.77),hs-cTnT 1.20(95%CI 0.88-1.63),无差异。
- 院内死亡率:轻度高碳酸血症组39%(112/287)vs 正常碳酸血症组40.5%(124/306),RR 0.97(95%CI 0.82-1.14)。
- 6个月神经功能良好结局:轻度高碳酸血症组44.3%(129/267)vs 正常碳酸血症组48.5%(125/282),RR 1.09(95%CI 0.92-1.29)。
- 成功PCI的STEMI患者中,按治疗分配各结局均无显著差异。
- 前24小时乳酸清除率按治疗分配无差异。
证据类型、等级与局限
- 证据类型:TAME试验的事后探索性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在院外心脏骤停后昏迷的STEMI患者中,靶向轻度高碳酸血症未改变心肌损伤、院内死亡率或6个月神经功能结局,不支持为改善这些结局而常规采用该策略。
- 成功PCI的STEMI患者中同样未见获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Targeting mild hypercapnia reduced myocardial injury in a single-centre cohort of STelevation myocardial infarction (STEMI) patients from the multinational Targeted Therapeutic Mild Hypercapnia after Resuscitated Cardiac Arrest (TAME) trial. We examined the effect of mild hypercapnia on myocardial injury and outcomes in all acute myocardial infarction (AMI) patients of the TAME trial.
METHODS: Post-hoc exploratory study of the TAME trial that compared the effect of targeted mild hypercapnia or normocapnia in comatose adults after out-of-hospital cardiac arrest (OHCA). The primary outcome was myocardial injury assessed by peak high-sensitivity cardiac troponin T (hs-cTnT) or troponin I (cTnI) levels during hospitalisation in STEMI and successfully percutaneous coronary intervention (PCI) treated STEMI patients. Secondary outcomes included lactate clearance, in-hospital mortality, and neurological outcome at six months.
RESULTS: We studied 810 of 1700 TAME patients (49%) that were diagnosed with AMI. Of these, 593 had STEMI (73%), with 287 patients (48%) in the mild hypercapnia group and 306 (52%) in the normocapnia group. Troponin levels were available for 562 STEMI patients (95%). There was no difference in troponin level (ratio of geometric means (95% (CI) (mild hypercapnia/normocapnia) cTnI 1.18 (0.79-1.77), hs-cTnT 1.20 (0.88-1.63)) or lactate clearance over the first 24 h according to treatment allocation. In-hospital mortality in STEMI patients was 112 of 287 (39%) vs. 124 of 306 (40.5%) patients in the mild hypercapnia group vs. normocapnia group, respectively (Relative Risk 0.97, 95% CI, 0.82-1.14). At six months, 129 of 267 (44.3%) vs. 125 of 282 (48.5%) patients in the mild hypercapnia group vs normocapnia group had a favourable neurological outcome (Relative Risk 1.09, 95% CI, 0.92-1.29). For successful PCI STEMI patients there were no significant differences in any outcomes according to treatment allocation.
CONCLUSION: Among STEMI patients of the TAME trial, myocardial injury, in-hospital mortality, and neurological outcome at six months were not modified by allocation to targeted mild hypercapnia.
参考来源
- Andersen GØ, Bailey M, Qvigstad E, et al. Effects of mild hypercapnia on myocardial injury among ST-elevation myocardial infarction patients after out-of-hospital cardiac arrest: a exploratory post-hoc study of the TAME trial. Resuscitation. 2026. PMID: 41577226. doi:10.1016/j.resuscitation.2026.110982
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。